ZORYVE® IT
RELIEVE IT
ANYWHERE
ZORYVE has the power and versatility
to be your everyday topical1,2
CREAM 0.15% FOR
ATOPIC DERMATITIS

DOWN TO 6 YEARS OLD

FOAM 0.3% FOR
SEBORRHEIC DERMATITIS

DOWN TO 9 YEARS OLD

CREAM 0.3% FOR
PLAQUE PSORIASIS

DOWN TO 6 YEARS OLD

NOW AVAILABLE: FOAM 0.3% FOR
PLAQUE PSORIASIS

DOWN TO 12 YEARS OLD

ZORYVE® (roflumilast) is a once-daily and steroid-free prescription topical

Symptoms illustrated.
Not actual patients.

ZORYVE (roflumilast) cream 0.15%, ZORYVE (roflumilast) foam 0.3% and ZORYVE (roflumilast) cream 0.3%
Rapid, reliable
results anywhere1-4
Consistently well tolerated
and safe1,2,5
Patient-friendly cream and foam formulations
for easy, long-term disease control1,2,6-8

ATOPIC DERMATITIS: 31% of patients achieved vIGA-AD Success at Week 4 with ZORYVE vs 14% with vehicle, some as early as Week 1.
32% of patients achieved WI-NRS Success at Week 4 with ZORYVE vs 17% with vehicle, with results observed within 24 hours.9,10

SEBORRHEIC DERMATITIS: 77% of patients achieved IGA Success with ZORYVE at Week 8 vs 53% with vehicle, some as early as Week 2.2,9

PLAQUE PSORIASIS: 40% of patients achieved IGA Success with ZORYVE cream at Week 8 vs 7% with vehicle, some as early as Week 4.1,11
63% of patients achieved S-IGA Success with ZORYVE foam at Week 8 vs 21% with vehicle, some as early as Week 2.9
42% of patients achieved B-IGA Success with ZORYVE foam at Week 8 vs 15% with vehicle, some as early as Week 2.9

See the study design below.